RE:Promis to present at conferenceretiredcop wrote: This is what I am looking forward to this week ...we have had very little info on the vaccine
Title: Rational Design of a Vaccine for Alzheimer’s Disease Using Computationally-Derived Conformational B Cell Epitopes to Selectively Target Toxic Amyloid-Beta Oligomers
Session: S26: Experimental Therapeutics in Dementia (abstract #4532)
Presenter: Dr. Johanne Kaplan
Date & Time: April 25, 2023 at 1:36 p.m. ET
The news release of September 22, 2022, did give us some information about the vaccine.
https://d1io3yog0oux5.cloudfront.net/_c3909589c54dbb5cb2db2e2aad5f3a0f/promisneurosciences/news/2020-09-22_ProMIS_Neurosciences_to_develop_multivalent_34.pdf
"A vaccine capable of inducing an effective antibody response against amyloid-beta toxic oligomers (ABOs) could be administered prophylactically to at-risk individuals to prevent the development of symptomatic disease. Additionally, the vaccine could be given therapeutically to individuals living with a diagnosis of AD to inhibit further disease." (bolding added)
What is not spelled out is how often is the vaccine administered.
G1945V